Emerging Medicinal Plants and Their Therapeutic Potential in Hyperuricemia and Gout Management: A Review
Main Article Content
Abstract
Hyperuricemia is a condition characterized by elevated concentrations of uric acid in the body which is a metabolic disorder that leads to gout. It is also linked to other complications such as renal disorders, heart diseases, and metabolic syndrome. Even though treatments such as allopurinol, febuxostat, colchicine, and non-steroidal anti-inflammatory medicines have proved to be quite effective in the management of hyperuricemia but causes side effects, thus responsible for health risks on prolonged usage. Thus, there is need to much focus on herbal treatments of hyperuricemia and gout.This review explores the pathophysiology behind hyperuricemia-gout association of various plants like Dendrobium officinale, Mollugo pentaphylla, Sophora japonica, Aster glehni, Eucommia ulmoides, Mesona procumbens, among others. These plants have been reviewed extensively in the literature for their potential medicinal value. These were based on the various pharmacological activities they possess through mechanisms of xanthine oxidase inhibition, renal urate transporter modulation, anti-inflammatory activity, and antioxidant-mediated protection against nephropathy. While promising preclinical data exist, more research is needed for their clinical utility.
References
1. Wang Y, Zhang Y, et al. Gout: global epidemiology, risk factors, comorbidities and complications: a narrative review. BMC Musculoskelet Disord. 2024;25:1037
2. Wang C, Dai J. Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components. Front Nutr. 2023;10:1186161.
3. Burden of gout among different WHO regions, 1990–2019: estimates from the Global Burden of Disease study. Sci Rep. 2024;14:61616.
4. Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69.
5. Perez-Ruiz F, Dalbeth N, Bardin T. A review of uric acid, crystal deposition disease, and gout. Adv Ther. 2015;32(1):31–41.
6. Yang Y, Zhang Y, Liu X, et al. A review on gout: Looking back and looking ahead. Int Immunopharmacol. 2024;126:109977.
7. Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87–114.
8. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8–14.
9. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039–2052.
10. Richette P, Bardin T. Gout. Lancet. 2010;375(9711):318–328.
11. Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–390.
12. Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87–114.
13. So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13(11):639-647.
14. Cos P, Ying L, Calomme M, Hu JP, Cimanga K, Van Poel B, et al. Structure–activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod. 1998;61(1):71–76.
15. Nutmakul T. A review on benefits of quercetin in hyperuricemia and gouty arthritis. J Saudi Pharm Soc. 2022;30(7):918–926.
16. Cianciullo D, et al. Anti-inflammatory and hypouricemic effect of bioactive compounds. Cell Biochem Funct. 2022;44(11):352.
17. Cos P, et al. Structure–activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod. 1998;61(1):71–76.
18. Wang C, Dai J. Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components. Front Nutr. 2023;10:1186161
19. Park JE, Yeom Z, Park KT, et al. Hypouricemic effect of ethanol extract of Aster glehni leaves in potassium oxonate-induced hyperuricemic rats. Clin Nutr Res. 2018;7(2):126-135.
20. Jeong J, Lim MK, Han EH, et al. Regulation of urate transporters and inflammatory pathways by Aster glehni extract in hyperuricemic rats. Food Sci Biotechnol. 2022;31(13):1729-1739.
21. Lee YM, Shon EJ, Kim OS, Kim DS. Effects of Mollugo pentaphylla 12 extract on monosodium urate crystal-induced gouty arthritis in mice. BMC Complement Altern Med. 2017;17(1):447.
22. Wang F, Zhao X, Su X, Song D, Zou F, Fang L. Isorhamnetin from Sophora japonica ameliorates uric acid levels and renal function in hyperuricemic mice. Food Funct. 2021;12(24):12503-12512.
23. Jhang J, Ong J, Lu C, Hsu C, Lin J, Liao J, Yen G. Hypouricemic effects of Mesona procumbens Hemsl, through modulating xanthine oxidase activity in vitro and in vivo. Food Funct. 2016:7(10):4239-4246.
24. Abu-Gharbieh E, Shehab NG, Almasri IM, Bustanji Y. Antihyperuricemic and xanthine oxidase inhibitory activities of Tribulus arabicus and its isolated compound, ursolic acid: In vitro and in vivo investigation and docking simulations. PLoS One. 2018;13(8):e020257.
25. Fang C, Chen L, He M, et al. Hypouricemic effects of Eucommia ulmoides in experimental hyperuricemia models. Pharm Biol. 2019;57(1):112-119.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.